Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Co-expression of microrna and mrna in cytogenetically normal acute myeloid leukemia patients [mRNA]

ABSTRACT: Co-expression of microrna and mrna in cytogenetically normal acute myeloid leukemia patients [mRNA]

PROVIDER: PRJNA598037 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Co-expression of microrna and mrna in cytogenetically normal acute myeloid leukemia patients

Project description:Co-expression of microrna and mrna in cytogenetically normal acute myeloid leukemia patients

| PRJNA598034 | ENA

Co-expression of microrna and mrna in cytogenetically normal acute myeloid leukemia patients [miRNA]

Project description:Co-expression of microrna and mrna in cytogenetically normal acute myeloid leukemia patients [miRNA]

| PRJNA598036 | ENA

Co-expression of microrna and mrna in cytogenetically normal acute myeloid leukemia patients [mRNA]

Project description:The study integrated both miRNA and mRNA profiles to explore novel miRNA-mRNA interactions that affect the regulatory patterns in de novo CN-AML. A total of 637 significant negative correlations (FDR <0.05) were reported. Network analysis revealed a cluster of 12 miRNAs that represents the majority of the mRNA targets. Within the cluster, five miRNAs; miR-495-3p, miR-185-5p, let-7i-5p, miR-409-3p, and miR-127-3p were suggested to play a pivotal role in the regulation of CN-AML as they are associated with negative regulation of myeloid leukocyte differentiation, negative regulation of myeloid cell differentiation, positive regulation of haematopoiesis, and hematopoiesis and its regulation. Three novel interactions in CN-AML were predicted, let-7i-5p:HOXA9, miR-495-3p:PIK3R1 and miR-495-3p:CDK6 which are responsible in regulating myeloid cell differentiation in CN-AML.

2019-12-30 | GSE142698 | GEO

Co-expression of microrna and mrna in cytogenetically normal acute myeloid leukemia patients [miRNA]

2019-12-30 | GSE142699 | GEO

microRNA-expression profiling according to MN1 mRNA expression levels in de novo cytogenetically normal acute myeloid leukemia patients aged 60 years or older.

Project description:microRNA-expression profiling according to MN1 mRNA expression levels in de novo cytogenetically normal acute myeloid leukemia patients aged 60 years or older.

2011-10-20 | E-TABM-1190 | biostudies-arrayexpress

Gene-expression profiling according to MN1 mRNA expression levels in de novo cytogenetically normal acute myeloid leukemia patients aged 60 years or older.

Project description:Gene-expression profiling according to MN1 mRNA expression levels in de novo cytogenetically normal acute myeloid leukemia patients aged 60 years or older.

2011-10-20 | E-TABM-1189 | biostudies-arrayexpress

Co-expression of microrna and mrna in cytogenetically normal acute myeloid leukemia patients

Project description:This SuperSeries is composed of the SubSeries listed below.

2019-12-30 | GSE142700 | GEO

microRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia patients 60 years.\//\<

Project description:microRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia patients <60 years.

2012-06-09 | E-TABM-1166 | biostudies-arrayexpress

MicroRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia patients >=60 years.

Project description:MicroRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia patients >=60 years.

2012-06-09 | E-TABM-1167 | biostudies-arrayexpress

Prognostic DNA Methylation Patterns in Cytogenetically Normal Acute Myeloid Leukemia are predefined by Stem Cell Chromatin Marks [methylation]

Project description:Cytogenetically normal acute myeloid leukemia (CN-AML) comprise between forty and fifty percent of all adult acute myeloid leukemia (AML) cases. In this clinically diverse group molecular aberrations such as FLT3ITD, NPM1 and CEBPA mutations recently have added to the prognostic accuracy. Aberrant DNA methylation is a hallmark of cancer including AML. We investigated in total 89 CN-AML samples in a test and a validation cohort for genome-wide promoter DNA methylation with Illumina Methylation Bead arrays and compared them to normal myeloid precursors and global gene expression. IDH and NPM1 mutations were associated with different methylation patterns (p=0.0004 and 0.04, respectively). Genome-wide methylation levels were elevated in IDH mutated samples (p=0.006). We observed a negative impact of DNA methylation on transcription. Genes targeted by Polycomb group (PcG) proteins and genes associated with bivalent histone marks in stem cells showed increased aberrant methylation in AML (p<0.0001). Furthermore, high methylation levels of PcG target genes were independently associated with better progression free (OR 0.47, p=0.01) and overall survival (OR 0.36, p=0.001). In summary, genome wide methylation patterns show preferential methylation of PcG targets with prognostic impact in CN-AML. Genome wide methylation pattern study of cytogenetically normal AML

2011-09-20 | E-GEOD-32251 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data